{"id":"W4765708","doi":"10.2165/00044011-200929050-00003","title":"Diary and Patient-Reported Outcomes in Patients with Severe Overactive Bladder Switching from Tolterodine Extended Release 4 mg/day to Solifenacin Treatment","year":2009,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Bayer Canada; Astellas Pharma; GlaxoSmithKline; Pfizer","keywords":"Tolterodine; Overactive bladder; Solifenacin; Medicine; Tolerability; Urology; Adverse effect; Nocturia; Urinary urgency; Internal medicine; Urinary system","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008370242,0.000196103,0.0008671118,0.0005035115,0.0003251124,0.0006582421,0.000257689,0.0004687584,0.001170522],"category_scores_gemma":[0.005674189,0.0001338602,0.0008401509,0.0006754349,0.0001701762,0.0006324628,0.0003590006,0.0007790126,0.0001295464],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003271523,"about_ca_system_score_gemma":0.000276675,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001691607,"about_ca_topic_score_gemma":0.002058196,"domain_scores_codex":[0.9994377,0.0001871838,0.0001075819,0.00006351551,0.0001111125,0.00009273969],"domain_scores_gemma":[0.9966383,0.001045928,0.001353282,0.0001221726,0.0002600936,0.000580261],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004693397,0.0003802626,0.9829652,0.00009055083,0.00051882,0.0001770969,0.0002529443,0.0002802624,0.0004295581,0.00002677349,0.0002462934,0.009938787],"study_design_scores_gemma":[0.0001720934,0.001505163,0.9969079,0.00001260548,0.0001846504,0.000258275,0.0001990976,0.0004790673,0.00008962416,0.00002367213,0.0001554544,0.00001246504],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998897,0.0003015423,0.00002548609,0.00004450112,0.00001076461,0.00001002597,0.0002155622,0.000002036799,0.0004932158],"genre_scores_gemma":[0.9994959,0.00008544257,0.00003040329,0.00003233331,0.00000927676,0.000007661034,0.0002639037,6.468257e-7,0.00007448588],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001691607,"threshold_uncertainty_score":0.004426658,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03128411834866037,"score_gpt":0.3371129593835576,"score_spread":0.3058288410348973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}